Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer

Published:2015-04 Issue: Volume:46 Page:13-25
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Zhao Xiao,Li Feng,Li Yiye,Wang Hai,Ren He,Chen Jing,Nie Guangjun,Hao Jihui

Funder

MoST

National Distinguished Young Scientists program

National Natural Science Foundation of China

Key Program of Natural Science Foundation of Tianjin

Major Anticancer Technologies R&D Program of Tianjin

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference35 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2014

2. Metastatic pancreatic cancer: is gemcitabine still the best standard treatment?;Di Marco;Oncol Rep,2010

3. The pancreas cancer microenvironment;Feig;Clin Cancer Res,2012

4. Hypoxia signalling in cancer and approaches to enforce tumour regression;Pouyssegur;Nature,2006

5. Targeted replacement of hypoxia-inducible factor-1α by a hypoxia-inducible factor-2α knock-in allele promotes tumor growth;Covello;Cancer Res,2005

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing siRNA cancer therapy: Multifaceted strategies with lipid and polymer-based carrier systems;International Journal of Pharmaceutics;2024-09

2. Converging paths: Microneedle-based dual intervention of IL-23/IL-17 axis and granuloma formation in rheumatoid nodules;Medical Hypotheses;2024-08

3. Application of nanoparticles in breast cancer treatment: a systematic review;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-03

4. Lipid nanoparticles for RNA delivery: Self-assembling vs driven-assembling strategies;Advanced Drug Delivery Reviews;2024-05

5. Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer;Cancers;2024-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3